LobbyingBlink Health lobbying by quarter
Blink Health's latest lobbying report covers Q1 2026, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Health Issues and Pharmacy.
Blink Health
- Latest quarter
- No record
- Q2 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $75K | 1 |
| Q1 2023 | $75K | 1 |
| Q2 2023 | $80K | 1 |
| Q3 2023 | $80K | 1 |
| Q4 2023 | $80K | 1 |
| Q1 2024 | $80K | 1 |
| Q2 2024 | $80K | 1 |
| Q3 2024 | $80K | 1 |
| Q4 2024 | $80K | 1 |
| Q1 2025 | $80K | 1 |
| Q2 2025 | $80K | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 0 |
Policy issues the reports name
- Health issues11 reports
- Pharmacy11 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES11 reports
- SENATE11 reports
Firms it paid
| Firm | ||
|---|---|---|
| Foley & Lardner | $870K | 14 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 04/20for Q1 | Foley & Lardner | Under $5,000 |
| 01/19for Q4 2025 | Foley & Lardner | Under $5,000 |
| 25/10/18for Q3 2025 | Foley & Lardner | Under $5,000 |
| 25/07/17for Q2 2025 | Foley & Lardner | $80K |
| 25/04/17for Q1 2025 | Foley & Lardner | $80K |
| 25/01/16for Q4 2024 | Foley & Lardner | $80K |
| 24/10/21for Q3 2024 | Foley & Lardner | $80K |
| 24/07/21for Q2 2024 | Foley & Lardner | $80K |
| 24/04/19for Q1 2024 | Foley & Lardner | $80K |
| 24/01/21for Q4 2023 | Foley & Lardner | $80K |
| 23/10/19for Q3 2023 | Foley & Lardner | $80K |
| 23/07/19for Q2 2023 | Foley & Lardner | $80K |
| 23/04/20for Q1 2023 | Foley & Lardner | $75K |
| 23/01/20for Q4 2022 | Foley & Lardner | $75K |